MEDTIL
The computed 12-month bankruptcy probability of MEDTIL is 1.0% (low). The 2024 annual accounts show equity of €165k and a net result of €-17k. Equity is shrinking by ~19% per year across the filed fiscal years. Its solvency ranks better than 54% of 1697 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €165k |
| Net result | €-17k |
| Better than sector | 54% |
| Active | 4 yrs |
Fragile profile, watch profitability in particular.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 17.7% | 14.3% | |
| Net result | €-17k | €0 | |
| Equity | €165k | €108k | |
| Gross operating margin | €-17k | €52k | |
| Total assets | €937k | €1.50M |
| Fiscal year | 2024 |
|---|---|
| Deposit | verkort |
| Revenue | - |
| EBITDA | - |
| Net profit | €-17k |
| Cash flow | - |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €937k |
| Equity | €165k |
| Debt | €771k |
| of which ≤ 1y | €67k |
| of which > 1y | €705k |
| Working capital | €66k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 1.99 |
| Quick ratio | 1.99 |
| Working capital ratio | 7.1% |
| Solvency | 17.7% |
| Debt / equity | 4.66 |
| Long-term debt ratio | 4.26 |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | -1.8% |
| ROE | -10.0% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €937k |
| Fixed assets | 21/28 | €804k |
| Tangible fixed assets | 22/27 | €804k |
| Current assets | 29/58 | €133k |
| Amounts receivable within one year | 40/41 | €129k |
| Cash & bank | 54/58 | €4k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €937k |
| Equity | 10/15 | €165k |
| Contributions / capital | 10/11 | €250k |
| Accumulated profits (losses) | 14 | €-85k |
| Amounts payable | 17/49 | €771k |
| Amounts payable after one year | 17 | €705k |
| Amounts payable within one year | 42/48 | €67k |
| Trade debts payable within one year | 44 | €67k |
| Income statement | ||
| Gross operating margin | 9900 | €-17k |
| Operating result | 9901 | €-18k |
| Financial income | 75 | €1k |
| Financial charges | 65 | €285 |
| Result before taxes | 9903 | €-17k |
| Net result for the period | 9904 | €-17k |
| Result to be appropriated | 9905 | €-17k |
-
Current30-06-2025 → present
Former directors (1)
-
Former- → 30-06-2025
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| KPMG Bedrijfsrevisoren BV/SRLCurrent Statutory auditor · represented by Christophe Van Parys |
- | 23-02-2026 → present |
| NACE primary | Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen(68203) |
| Legal form | Private limited company(610) |
| Incorporation | 14-03-2022 |
| Status | Active |
| Postal code | 8900 |
Each band states what its claims rest on. A board seat is influence over the board, not ownership. Court mandates (receiver, interim administrator) and liquidation mandates do not link companies and are therefore absent here; they belong under Directors & mandates.
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 33305B1021/00D002 | Flanders | 5,629 m² | 1 · 1,997 m² | 8.8 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
23-02-2026 Christophe Van Parys reappointed as statutory auditor
- Christophe Van Parys, Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Christophe Van Parys",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "KPMG Bedrijfsrevisoren BV/SRL",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "De algemene vergadering herbenoemt de commissaris voor een periode van 3 jaar tot de datum van de A.V. te houden in 2028 over het boekjaar eindigend per 31/12/2027."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0783.387.440",
"name_full": "MEDTIL",
"legal_form": "BV"
}
}19-09-2025 1 director appointed, 1 resigning
- Michael GHEYSENS, Bestuurder
- Michael GHEYSENS, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Michael GHEYSENS",
"address": null,
"birth_date": null
},
"effective_date": "2025-06-30",
"evidence_quote": "Het ontslag van de heer Michael GHEYSENS, wonende te 9830 Sint-Martens-Latem, Nelemeersstraat 9. en dit met ingang van 30/06/2025."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Michael GHEYSENS",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0844615028",
"name": "GHEMIC",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-06-30",
"evidence_quote": "De benoeming van de BV \u0022GHEMIC\u0022, met zetel te 9830 Sint-Martens-Latem, Nelemeersstraat 9 en ondernemingsnummer 0844.615.028 (RPR Gent, afdeling Gent) vertegenwoordigd door haar vaste vertegenwoordiger, de heer Michael GHEYSENS, wonende te 9830 Sint-Martens-Latem, Nelemeersstraat 9, en dit met ingang"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0783.387.440",
"name_full": "MEDTIL",
"legal_form": "BV"
}
}16-03-2022 Incorporation of a new BV
Technical details
{
"kind": "oprichting",
"seat": "8900 Ieper, Zwaanhofweg 10",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": {
"kbo": null,
"name": "GREEN ENERGY INVESTMENTS"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "Aandelen",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": "GREEN ENERGY INVESTMENTS",
"contribution_type": "cash",
"amount_paid_in_eur": 250000,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 250000,
"amount_subscribed_eur": 250000,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 250000,
"subject_company": {
"kbo": "0783.387.440",
"name_full": "MEDTIL",
"legal_form": "BV"
},
"initial_directors": [],
"incorporation_date": "2022-03-11",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | MEDTIL |